INTRODUCTION

CONTINUOUS MEASUREMENT OF BLOOD PRESSURE (BP) IS READILY AVAILABLE IN CLINICAL SETTINGS SUCH AS INTENSIVE-CARE MONITORING OF CRITICALLY
ill infants and adults, where it is usually obtained invasively via arterial catheterization. However, continuous measurement of BP is also desirable for the investigation of the cardiovascular system and its autonomic control during sleep, in which arterial catheterization is problematic. In particular, there has been growing interest in studies related to obstructive sleep apnea syndrome 1,2 and the sudden infant death syndrome, [3] [4] [5] in which altered autonomic BP control during sleep may play a crucial role in the pathophysiology of such syndromes.
Autonomic control of the cardiovascular system relies on the baroreflex mechanism for the short-term control of BP variations. Baroreflex sensitivity (BRS) is commonly assessed by power spectral analysis 6 or spontaneous sequence analysis, [7] [8] [9] with both approaches being dependent on accurate, beat-to-beat BP measurement. Because of ethical constraints on arterial catheterization in infants for research purposes, previous assessments of BRS during sleep have relied on noninvasive techniques, such as oscillometry, that allow only intermittent measurements. [10] [11] [12] A new noninvasive device, the Finapres TM (TNO, The Netherlands) and its portable version, the Portapres TM (FMS, Finapres Medical Systems BV, The Netherlands), have become available for the continuous measurement of BP in adults. The Finapres TM operates via a photoplethysmographic cuff designed for the adult finger and utilizes the volume clamp method of Penaz 13 for BP determination. Several studies have assessed the use of the Finapres TM in preterm infants, with application of the adult-sized finger cuff to the infant's wrist, [14] [15] [16] but, as yet, validation of this approach is not complete. Of these studies, 2 reported a good agreement between intraarterial catheters and Finapres TM /Portapres TM in measurements of systolic (SAP) and diastolic (DAP) arterial pressure. 14, 15 However, in the most recent study, Andriessen et al 16 concluded that the Finapres TM provided absolute BP measurements of limited accuracy, though the device accurately measured beat-to-beat changes in BP. In addition to disagreement concerns relating to absolute accuracy, these previous studies have been limited to a single measurement in each infant, so that the reproducibility (precision) of repeated measurements within a subject is unknown. Furthermore, although the Finapres TM has been used to determine BRS, 17 no comparison with arterial-catheter BRS measurements and no assessment of sleep state has been made. Finally, there is currently no information on the measurement accuracy of the Finapres TM for mean arterial pressure (MAP), the value most commonly used in the clinical setting.
Recently, the Finometer TM (FMS, Finapres Medical Systems, The Netherlands), the successor of the Finapres TM , has become commercially available. The Finometer TM offers potential utility for recording beat-to-beat BP and contains an algorithm to reconstruct brachial artery pressure waveforms, but, as yet, this has not Study Objectives: Accuracy and precision of a noninvasive device for continuously measuring blood pressure (BP) (Finometer TM , FMS, The Netherlands) during sleep was assessed in preterm infants. Design: Absolute BP beat-to-beat values, interbeat changes, measurement precision, and baroreflex sensitivity were compared with BP measurements from intraarterial catheters. Participants: Ten preterm infants (gestational age 27-36 weeks; birth weight 964-2620 gm) were studied in the neonatal intensive care unit. Measurements and Results: The 2 modes of BP measurement were compared in 2-minute epochs (n = 10-12/infant). Mean arterial pressure, systolic arterial pressure, and diastolic arterial pressure were analyzed beat to beat, and baroreflex sensitivity was assessed using spontaneous sequence analysis. Mean differences for absolute BP (mm Hg) were as follows: mean arterial pressure, 3 (limits of agreement, -1 to 8); systolic arterial pressure, -4 (-8 to 1); and diastolic arterial pressure, 7 (4 to 10). Mean differences and limits of agreement for interbeat changes were essentially 0 for mean arterial pressure, systolic arterial pressure, and diastolic arterial pressure. Precision (± 95% confidence intervals, mm Hg) for the Finometer TM were mean arterial pressure ± 7, systolic arterial pressure ± 8, and diastolic arterial pressure ± 6. Precision was greater for the arterial catheter (mean arterial pressure ± 3, systolic arterial pressure ± 4, and diastolic arterial pressure ± 4). Baroreflex been validated in infants. Using arterial catheter measurements as the gold standard, the aims of this study were to measure BP during sleep using the Finometer TM and assess its capability in a number of key aspects: (1) accuracy of the absolute values and interbeat values of MAP, SAP, and DAP; (2) reproducibility of repeated measurements (precision) within a subject; and 3) accuracy in estimating BRS using spontaneous sequence analysis.
METHODS
The protocol for this study was approved by the Southern Health and Monash University Human Research Ethics Committees. Written parental consent was obtained for all subjects prior to commencement of the study.
Ten preterm infants (6 girls/4 boys) born at 27 to 36 weeks gestational age (mean 31 ± 1 weeks), with birth weights between 964 and 2620 gm (mean 1624 ± 215 gm) and Apgar scores of 2 to 8 (median 5) at 1 minute and 5 to 9 (median 8) at 5 minutes were recruited from the Neonatal Intensive Care Unit, Monash Medical Centre. Infants were studied 1 to 4 days postnatally. All infants were implanted with arterial catheters for intensive care monitoring prior to enrollment. Only infants approximately 1000 gm or larger were included in the selection criteria, because the BP cuff could not be applied appropriately in smaller infants.
Noninvasive BP Measurement (Finometer TM )
BP was measured with the Finometer TM cuff placed around the infant's wrist. In each subject, an appropriate-sized cuff (small, medium, or large) was selected, and 10 to 12 BP measurements were performed, each of 2 minutes duration, with a 2-minute rest period between successive measurements. The cyclic approach of 2 minutes (off-on) was chosen to avoid venous pooling in the infant's hand. Following the initial start-up calibration, the automatic calibration (Physiocal) was switched off to ensure an uninterrupted recording. All BP measurements were referenced to heart level via the built-in height-correction system.
Infant sleep states were scored as active sleep, quiet sleep, or indeterminate sleep using behavioral observations based on criteria described for preterm infants. BP was also measured directly via a preexisting 3.5 Fr or 5 Fr intraarterial catheter inserted into the umbilical (n = 9) or ulnar artery (n = 1). Decisions on inserting catheters, as well as the connection, zeroing, calibration, and maintenance were made independently by clinical staff for the care of the infant. To prevent clotting, the catheter was routinely flushed with heparinized saline. The catheter was connected to a pressure transducer and referenced to heart level with a fluid-filled manometer tube. TM BP measurements, were digitized using a 16-channel Powerlab system (ADInstruments, Sydney, Australia) at a sampling frequency of 400 Hz and stored on a personal computer running a specialized program for data storage, analysis, and signal display (Chart 5.0, ADInstruments).
Data Analysis Absolute BP Beat-to-Beat Values
Absolute beat-to-beat values of MAP, SAP, and DAP were obtained and matched by peak detection using Chart 5.0 software (ADInstruments) for both the Finometer TM (MAPf, SAPf, and DAPf) and catheter-system (MAPc, SAPc, and DAPc) BP measurements. Any sections within the 2-minute epoch containing movement artifact were excluded from further analysis. The difference between the catheter-system and the Finometer TM MAP, SAP, and DAP measurements were calculated for each beat, and a mean value was calculated for each 2-minute recording for each subject. Mean values were calculated for each subject; data was tested for normality using Kolmogorov-Smirnov test and compared using Bland-Altman analysis.
19
Interbeat Differences
Inter-beat differences between the Finometer TM and catheter system were compared by calculating the change in BP from one beat to the next and determining the difference between both systems for each beat. Values were compared using Bland-Altman analysis 19 for each subject.
Measurement Precision
Precision (reproducibility) was estimated using the method of Youden 20 as the 95% confidence interval (CI) of a single estimate: CI = 2S And,
Where, S equals the standard deviation of single estimate, d equals the difference of extremes of replicate measurements, and n is the number of replicates.
The number of replicate measurements (n) for the Finometer TM required to obtain an estimate with precision equal to that of the catheter system was calculated as:
Where Sf is the standard deviation of a single estimate for the Finometer TM and Sc is the standard deviation of a single estimate for the catheter system.
BRS Assessment
BRS was assessed using spontaneous sequence analysis. [7] [8] [9] Paired MAP and heart period (obtained from the electrocardiogram signal) sequences characterized by an increase or decrease of at 
Interbeat BP
Mean differences and limits of agreement for the interbeat changes recorded by the 2 systems were essentially 0 (< 0 .01 mm Hg) for each of MAP, SAP, and DAP. least 1 mm Hg during 3 or more consecutive beats were identified during each 2-minute epoch. BRS was calculated as the slope of the linear regression of MAP and the proceeding heart period for each sequence and averaged for each 2-minute epoch. Baroreflex sequences were defined by changes in MAP and heart period proceeding in the same direction, ie, sequences having positive slopes. A mean BRS was calculated for each infant for both Finometer TM and catheter-system MAP measurements. A paired Student's t test was used to compare BRS estimates both within each infant and for pooled subject means.
RESULTS
A typical example of simultaneous BP signals recorded by the catheter and Finometer
TM systems is presented in Figure 1 . Of the 10 infants studied, 1 infant was excluded (infant 3) because the mean catheter-system BP measurements for this infant were more than 2 SDs above the pooled subject mean, suggesting a zeroing error in this system.
A total of 101 2-minute epochs of simultaneous Finometer TM and catheter-system BP measurements were made. Of these, 58 epochs were analyzed free of movement artifacts, 55 epochs were recorded in active sleep, 1 in quiet sleep, and 2 in indeterminate sleep. Measurements in different sleep states were combined, and a total 11,637 paired beats were analyzed. BRS was assessed in 8 of 10 infants because 1 infant (infant 5) was excluded from BRS assessment related to a poor electrocardiogram signal.
Absolute BP
The ranges of BP (mm Hg) measured by the catheter system (c) and the Finometer TM (f) were 34 to 46 (MAPc) versus 39 to 47 (MAPf), 45 to 62 (SAPc) versus 46 to 61 (SAPf), and 23 to 43 (DAPc) versus 31 to 45 (DAPf). Mean differences (± SEM) and limits of agreement for MAP, SAP, and DAP are presented in Tables 1, 2, 
Figure 2b
Figure 2-Bland-Altman plots displaying mean differences for individual subjects (n = 9) between Finometer TM (f) and catheter-system (c) blood pressure measurement calculated on a beat-to-beat basis for (2a) mean arterial pressure (MAP), (2b) systolic arterial pressure (SAP), and (2c) diastolic arterial pressure (DAP). The solid line represents the mean difference for all subjects between both methods of measurements, and the dashed lines represents 95% limits of agreement (± 2 SD).
Precision of BP Measurements
The precision (95% CI, mm Hg) for each of the measurements was MAPc (-1 to 4) versus MAPf (-3 to 10), SAPc (-2 to 6) versus SAPf (-4 to 11), and DAPc (-2 to 5) versus DAPf (-3 to 9).
Numbers of replicates required for the Finometer TM to measure with a precision equal to that of the catheter were 5, 3, and 3 for MAP, SAP and DAP, respectively.
Baroreflex Sensitivity
BRS data are presented in Table 4 . There was no difference between the mean BRS calculated for the Finometer TM (1.74 ± 0.23) and the catheter system (1.56 ± 0.21, p = 0.2). The number of ramps identified to calculate BRS estimates in the catheter system (n = 713) was not different than that in the Finometer TM (n = 679).
DISCUSSION
Our study has demonstrated that the Finometer TM is a useful tool that can measure BP accurately and with high precision in preterm infants during sleep using the adult finger cuff placed around the wrist of the infant. Our findings support those of earlier workers, 14, 15 21 Absolute BP values of the Finometer TM underestimated SAP by a mean of -4 mm Hg and overestimated DAP by a mean of 7 mm Hg, indicating that the Finometer TM underestimates pulse pressure, although MAP accuracy is maintained. Our findings are similar to those of Harrington et al, 15 who analysed 5-minute epochs of BP in term neonates in intensive care and also found that the Portapres TM underestimated SAP (-2 ± 4 mm Hg) and overestimated DAP (4 ± 4 mm Hg). In contrast with our finding and those of Drouin et al 14 and Harrington et al, 15 Andriessen et al 16 concluded that the Finapres TM was of limited clinical value for estimating individual BP values because the difference from catheter values for SAP was as much as -6.5 or +17.6 mmHg and, for DAP, was -5.6 or +17.9 mm Hg in individual subjects. In this study, 16 the widely disparate values were for just 1 infant for SAP and for a different infant for DAP; when the data are averaged for the group, the difference for SAP is 2.2 mm Hg and DAP is 2.6 mm Hg, values similar to ours and to those of previous studies. 14, 15 In our study, the maximum individual differences for SAP and DAP were similar to those of Andriessen et al, 16 but the differences for MAP were much less (-1 to 7, Table 1 ).
The Finometer TM tracked interbeat changes in MAP, SAP, and DAP with high agreement, compared with the arterial catheter, with mean differences of 0 and limits of agreement also 0. In support of our data, Andriessen et al 16 achieved similarly accurate beat-tobeat changes for SAP and DAP. Importantly, that the Finometer TM can accurately track beat-to-beat changes in BP supports the use of this new technology in detecting rapid changes in BP, which are essential when assessing autonomic cardiovascular control. Furthermore, our study has shown that BRS in the time domain can be accurately assessed from Finometer TM BP measurements, because there was no difference compared with BRS derived from arterial-catheter measurements. The BRS values we obtained from spontaneous sequence analysis (arterial catheter: 1.56 ± 0.21 ms/mm Hg; Finometer TM : 1.74 ± 0.23 ms/mm Hg) are similar to those previously reported for preterm infants at similar gestational ages (1.80 ± 0.14 ms/mm Hg) using the technique of spontaneous sequence analysis. 22 A novel approach of our study was to estimate the precision of each method by calculating the 95% CI for a single estimate. The precision of the catheter system was somewhat greater than the Finometer TM because the 95% CIs were less; for example, for MAP, the 95% CI was -1 to 4 mm Hg versus -3 to 10 mm Hg, respectively. Importantly, using the precision calculation described by Youden, 20 we have shown that, with 5 or fewer replicate measurements, the Finometer TM precision is equal to that of the catheter system. The source of greater precision of the catheter system is uncertain, but it may represent a greater intrinsic stability of the measurement system or a lesser sensitivity to physiologic BP changes. Alternatively, the lesser precision of the Finometer TM could be due to the displacement of the cuff between replicated measurements. Because the majority of measurements were recorded during active sleep, the position of the cuff on the wrist could have altered due to the characteristic body movements of this state. Therefore, during a research study, this could be rectified by ensuring that the wrist with the BP cuff is kept still or is confined to 1 position as the infant sleeps.
Despite the overall good agreement between methods of measurement, we did observe variation in mean differences and 95% limits of agreement between subjects, with the Finometer TM both underestimating and overestimating absolute BP in some infants. This variation may have been due to a poor-fitting cuff in these particular infants. The inflatable cuff operates to clamp the diameter of the artery constant by opposing pulsatile changes occurring during each heart beat. Any change is counteracted by a fast pressure servo controller that increases or decreases pressure accordingly in the inflatable bladder. If the BP cuff is too large, this could lead to an overestimation of BP caused by a pressure gradient over the air bladder due to overinflation. Conversely, if the cuff is too small or wrapped too tightly, this could result in an underestimation of BP. This may explain the overestimation of BP in infant 1, who had the lowest birth weight (964 gm) of all infants studied. Despite using the smallest cuff on this infant, the Finometer TM overestimated DAP by 13 mm Hg, which may suggest that the cuff was too large. Other authors have also reported considerable variation in bias between subjects and have questioned whether or not it is acceptable to pool individual BP The mean baroreflex sensitivity (BRS) ± SEM is presented in ms/mm Hg.
Noninvasive Blood Pressure Measurement In Infants-Yiallourou et al values. 16 However, as evident from our Bland-Altman analysis, in particularly for MAP (Figure 2a) , the majority of individual subject differences are close to 0, and mean differences were normally distributed. Therefore, in a research setting with adequate repeated measurements in each subject and normally distributed data, we are confident that a pooled comparison will be representative of population estimates. A second limitation was that because preterm infants spend the majority of their sleeping time in active sleep, the majority of our measurements (55/58) were made in this state, and potential sleep-state effects could not be examined. However, because physiologic variability is less in quiet sleep, we anticipate that any differences in the measurement systems would be less in this state.
In summary, our study has found that the Finometer TM is a useful tool to measure both absolute and beat-to-beat changes in BP in infants during sleep with the adult-sized finger cuff placed around the wrist. The continuous noninvasive measurement of BP will provide new opportunities to study the maturation of baroreflex control of BP in infants and may provide important insights into a number of infant sleep-related problems such as sudden infant death syndrome, which has been proposed to result from a failed baroreflex response to profound hypotension. 23 
